Dexin Valuation
Is 3349 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Sales gegen Gleichaltrige
Price-To-Sales gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 3349 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: 3349 (NT$26.3) wird über unserer Schätzung des Fair Value (NT$2.37) gehandelt.
Deutlich unter dem Marktwert: 3349 über unserer Schätzung des beizulegenden Zeitwerts gehandelt wird.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 3349?
Other financial metrics that can be useful for relative valuation.
What is 3349's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | NT$973.74m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.4x |
Enterprise Value/EBITDA | -9.6x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 3349's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.8x | ||
8093 Enermax Technology | 2.1x | n/a | NT$687.7m |
3057 Promise Technology | 1.9x | n/a | NT$1.1b |
3287 Kworld ComputerLtd | 2.3x | n/a | NT$1.5b |
2380 Avision | 0.7x | n/a | NT$1.4b |
3349 Dexin | 2.5x | n/a | NT$973.7m |
Price-To-Sales gegen Gleichaltrige: 3349 ist auf der Grundlage des Price-To-Sales Verhältnisses (2.5x) im Vergleich zum Durchschnitt der Vergleichsgruppe (1.8x) teuer.
Price to Earnings Ratio vs Industry
How does 3349's PE Ratio compare vs other companies in the TW Tech Industry?
Price-To-Sales gegen Industrie: 3349 ist teuer, wenn man sein Price-To-Sales Verhältnis (2.7x) mit dem TW Tech Branchendurchschnitt (1.6x) vergleicht.
Price to Sales Ratio vs Fair Ratio
What is 3349's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 2.5x |
Fair PS Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Sales Fair Ratio von 3349 für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.